225 related articles for article (PubMed ID: 11050249)
21. Slow component of axonal transport is impaired in the proximal axon of transgenic mice with a G93A mutant SOD1 gene.
Sasaki S; Warita H; Abe K; Iwata M
Acta Neuropathol; 2004 May; 107(5):452-60. PubMed ID: 15029446
[TBL] [Abstract][Full Text] [Related]
22. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease.
Vande Velde C; Garcia ML; Yin X; Trapp BD; Cleveland DW
Neuromolecular Med; 2004; 5(3):193-203. PubMed ID: 15626820
[TBL] [Abstract][Full Text] [Related]
23. Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene.
Sasaki S; Warita H; Murakami T; Abe K; Iwata M
Acta Neuropathol; 2004 May; 107(5):461-74. PubMed ID: 15029445
[TBL] [Abstract][Full Text] [Related]
24. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.
Wong PC; Pardo CA; Borchelt DR; Lee MK; Copeland NG; Jenkins NA; Sisodia SS; Cleveland DW; Price DL
Neuron; 1995 Jun; 14(6):1105-16. PubMed ID: 7605627
[TBL] [Abstract][Full Text] [Related]
25. Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking.
Laird FM; Farah MH; Ackerley S; Hoke A; Maragakis N; Rothstein JD; Griffin J; Price DL; Martin LJ; Wong PC
J Neurosci; 2008 Feb; 28(9):1997-2005. PubMed ID: 18305234
[TBL] [Abstract][Full Text] [Related]
26. Early and selective pathology of light chain neurofilament in the spinal cord and sciatic nerve of G86R mutant superoxide dismutase transgenic mice.
Morrison BM; Shu IW; Wilcox AL; Gordon JW; Morrison JH
Exp Neurol; 2000 Oct; 165(2):207-20. PubMed ID: 10993681
[TBL] [Abstract][Full Text] [Related]
27. Axonal atrophy in aging is associated with a decline in neurofilament gene expression.
Parhad IM; Scott JN; Cellars LA; Bains JS; Krekoski CA; Clark AW
J Neurosci Res; 1995 Jun; 41(3):355-66. PubMed ID: 7563228
[TBL] [Abstract][Full Text] [Related]
28. Human midsized neurofilament subunit induces motor neuron disease in transgenic mice.
Gama Sosa MA; Friedrich VL; DeGasperi R; Kelley K; Wen PH; Senturk E; Lazzarini RA; Elder GA
Exp Neurol; 2003 Nov; 184(1):408-19. PubMed ID: 14637110
[TBL] [Abstract][Full Text] [Related]
29. Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations.
Gowing G; Dequen F; Soucy G; Julien JP
J Neurosci; 2006 Nov; 26(44):11397-402. PubMed ID: 17079668
[TBL] [Abstract][Full Text] [Related]
30. A simple test to monitor the motor dysfunction in a transgenic mouse model of amyotrophic lateral sclerosis.
Collard JF; Julien JP
J Psychiatry Neurosci; 1995 Jan; 20(1):80-2. PubMed ID: 7865504
[TBL] [Abstract][Full Text] [Related]
31. Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1 G86R.
Audet JN; Gowing G; Julien JP
Neurobiol Dis; 2010 Oct; 40(1):245-50. PubMed ID: 20573565
[TBL] [Abstract][Full Text] [Related]
32. Effect of inhibition of superoxide dismutase on motor neurons during growth: comparison of phosphorylated and non-phosphorylated neurofilament-containing spinal neurons by histogram distribution.
Isonaka R; Katakura T; Kawakami T
Brain Res; 2012 Aug; 1470():11-6. PubMed ID: 22750289
[TBL] [Abstract][Full Text] [Related]
33. The single neurofilament subunit of the lamprey forms filaments and regulates axonal caliber and neuronal size in vivo.
Hall GF; Chu B; Lee S; Liu Y; Yao J
Cell Motil Cytoskeleton; 2000 Jul; 46(3):166-82. PubMed ID: 10913964
[TBL] [Abstract][Full Text] [Related]
34. Role of neurofilament aggregation in motor neuron disease.
Lin H; Schlaepfer WW
Ann Neurol; 2006 Oct; 60(4):399-406. PubMed ID: 17006927
[TBL] [Abstract][Full Text] [Related]
35. Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects?
Julien JP; Beaulieu JM
J Neurol Sci; 2000 Nov; 180(1-2):7-14. PubMed ID: 11090858
[TBL] [Abstract][Full Text] [Related]
36. Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport.
Marszalek JR; Williamson TL; Lee MK; Xu Z; Hoffman PN; Becher MW; Crawford TO; Cleveland DW
J Cell Biol; 1996 Nov; 135(3):711-24. PubMed ID: 8909545
[TBL] [Abstract][Full Text] [Related]
37. Pathways to motor neuron degeneration in transgenic mouse models.
Robertson J; Kriz J; Nguyen MD; Julien JP
Biochimie; 2002 Nov; 84(11):1151-60. PubMed ID: 12595144
[TBL] [Abstract][Full Text] [Related]
38. Motor neuron disease in transgenic mice with an H46R mutant SOD1 gene.
Sasaki S; Nagai M; Aoki M; Komori T; Itoyama Y; Iwata M
J Neuropathol Exp Neurol; 2007 Jun; 66(6):517-24. PubMed ID: 17549011
[TBL] [Abstract][Full Text] [Related]
39. Neuronal intermediate filaments.
Lee MK; Cleveland DW
Annu Rev Neurosci; 1996; 19():187-217. PubMed ID: 8833441
[TBL] [Abstract][Full Text] [Related]
40. Alterations in neurofilament mRNA in hereditary canine spinal muscular atrophy.
Muma NA; Cork LC
Lab Invest; 1993 Oct; 69(4):436-42. PubMed ID: 8231111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
